C0039996.jpg

Dr Jeffrey Aronson, Professor Sir Michael Rawlins at the Witness Seminar on, 'Clinical Pharmacology in the UK, c.1950-2000: Industry and Regulation' held by the History of Biomedicine Research Group, 20/09/2006.

Tags: 

industry

regulation

drug interaction

drug innovation

clinical trial

Thalidomide (Drug)

drug safety

Medicine Act

drug policy

drugs

clinical pharmacology

prescribing

GMC

Witness Seminar